Dr. Goff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle, WA 98109
Education & Training
University of WashingtonResidency, Radiation Oncology, 2018 - 2022
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2017 - 2018- Icahn School of Medicine at Mount SinaiClass of 2017
Certifications & Licensure
WA State Medical License 2018 - 2026- American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- Intratumoral STING agonist reverses immune evasion in PD-(L)1-refractory Merkel cell carcinoma: mechanistic insights from detailed biomarker analyses.Thomas Pulliam, Saumya Jani, Peter H Goff, Rashmi Bhakuni, Shira Tabachnick-Cherny
Journal for Immunotherapy of Cancer. 2024-10-14 - Merkel cell carcinoma refractory to anti-PD(L)1: utility of adding ipilimumab for salvage therapy.Tomoko Akaike, Austin J Jabbour, Peter H Goff, Song Y Park, Shailender Bhatia
Journal for Immunotherapy of Cancer. 2024-07-24 - Considerations Regarding Mohs Surgery for Early-Stage Merkel Cell Carcinoma.Suraj S Venna, Peter H Goff, Isaac Brownell
JAMA Dermatology. 2024-05-01
Press Mentions
World Health Organization Funding Threat May Help China Boost InfluenceApril 17th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
